Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | RGNX |
---|---|---|
09:32 ET | 12663 | 13.2 |
09:34 ET | 2329 | 13.17 |
09:36 ET | 1059 | 13.16 |
09:39 ET | 12201 | 13.22 |
09:43 ET | 1448 | 13.465 |
09:45 ET | 2840 | 13.38 |
09:48 ET | 632 | 13.26 |
09:50 ET | 12477 | 13.29 |
09:52 ET | 2023 | 13.3 |
09:54 ET | 1408 | 13.335 |
09:56 ET | 1509 | 13.44 |
09:57 ET | 939 | 13.32 |
09:59 ET | 1100 | 13.3 |
10:01 ET | 507 | 13.19 |
10:03 ET | 400 | 13.225 |
10:06 ET | 900 | 13.245 |
10:08 ET | 200 | 13.23 |
10:10 ET | 3705 | 13.09 |
10:14 ET | 1212 | 13.0101 |
10:15 ET | 1066 | 13.03 |
10:17 ET | 9297 | 13.08 |
10:19 ET | 764 | 13.03 |
10:21 ET | 500 | 13.04 |
10:24 ET | 200 | 13.07 |
10:26 ET | 200 | 13.03 |
10:28 ET | 915 | 12.99 |
10:30 ET | 200 | 13 |
10:32 ET | 7067 | 12.92 |
10:33 ET | 300 | 12.94 |
10:35 ET | 424 | 12.91 |
10:37 ET | 200 | 12.9 |
10:39 ET | 6050 | 12.93 |
10:42 ET | 400 | 12.94 |
10:44 ET | 904 | 12.87 |
10:46 ET | 400 | 12.87 |
10:48 ET | 1582 | 12.94 |
10:50 ET | 500 | 12.95 |
10:51 ET | 316 | 12.93 |
10:53 ET | 1877 | 12.905 |
10:55 ET | 600 | 12.92 |
10:57 ET | 1510 | 12.87 |
11:02 ET | 1652 | 12.965 |
11:04 ET | 600 | 12.99 |
11:06 ET | 200 | 13.03 |
11:08 ET | 404 | 13.01 |
11:09 ET | 200 | 13 |
11:11 ET | 1807 | 12.95 |
11:13 ET | 807 | 12.94 |
11:15 ET | 100 | 12.93 |
11:18 ET | 600 | 12.94 |
11:20 ET | 1300 | 12.96 |
11:22 ET | 952 | 12.97 |
11:24 ET | 200 | 12.96 |
11:26 ET | 200 | 12.99 |
11:27 ET | 300 | 12.98 |
11:29 ET | 122 | 12.995 |
11:31 ET | 300 | 12.97 |
11:33 ET | 200 | 12.97 |
11:36 ET | 100 | 12.98 |
11:38 ET | 289 | 12.98 |
11:40 ET | 1810 | 12.93 |
11:42 ET | 200 | 12.94 |
11:44 ET | 766 | 12.93 |
11:47 ET | 200 | 12.945 |
11:51 ET | 300 | 12.94 |
11:54 ET | 8762 | 12.87 |
11:56 ET | 1600 | 12.8923 |
11:58 ET | 621 | 12.8708 |
12:02 ET | 213 | 12.87 |
12:03 ET | 300 | 12.89 |
12:05 ET | 500 | 12.89 |
12:07 ET | 1148 | 12.92 |
12:09 ET | 300 | 12.92 |
12:14 ET | 200 | 12.9 |
12:16 ET | 200 | 12.93 |
12:20 ET | 1721 | 12.86 |
12:21 ET | 100 | 12.87 |
12:25 ET | 400 | 12.84 |
12:27 ET | 200 | 12.82 |
12:30 ET | 200 | 12.83 |
12:32 ET | 900 | 12.8155 |
12:34 ET | 100 | 12.84 |
12:36 ET | 200 | 12.83 |
12:38 ET | 712 | 12.82 |
12:39 ET | 735 | 12.82 |
12:43 ET | 1100 | 12.83 |
12:45 ET | 100 | 12.83 |
12:48 ET | 838 | 12.83 |
12:50 ET | 6043 | 12.785 |
12:52 ET | 1868 | 12.8 |
12:54 ET | 1164 | 12.81 |
12:56 ET | 2153 | 12.82 |
12:57 ET | 900 | 12.83 |
12:59 ET | 1050 | 12.84 |
01:03 ET | 300 | 12.84 |
01:06 ET | 1247 | 12.8 |
01:10 ET | 800 | 12.78 |
01:12 ET | 1308 | 12.72 |
01:14 ET | 628 | 12.72 |
01:15 ET | 600 | 12.71 |
01:19 ET | 300 | 12.67 |
01:21 ET | 200 | 12.66 |
01:24 ET | 1900 | 12.66 |
01:26 ET | 1845 | 12.66 |
01:28 ET | 242 | 12.65 |
01:30 ET | 700 | 12.66 |
01:32 ET | 4038 | 12.69 |
01:33 ET | 1609 | 12.66 |
01:35 ET | 200 | 12.66 |
01:37 ET | 1360 | 12.65 |
01:42 ET | 1700 | 12.64 |
01:44 ET | 4363 | 12.666 |
01:46 ET | 300 | 12.665 |
01:48 ET | 3298 | 12.705 |
01:50 ET | 1588 | 12.72 |
01:51 ET | 1632 | 12.725 |
01:53 ET | 1823 | 12.8 |
01:55 ET | 200 | 12.79 |
01:57 ET | 880 | 12.8 |
02:00 ET | 2947 | 12.805 |
02:02 ET | 609 | 12.805 |
02:04 ET | 1650 | 12.76 |
02:06 ET | 1090 | 12.73 |
02:08 ET | 100 | 12.72 |
02:11 ET | 108 | 12.725 |
02:15 ET | 200 | 12.71 |
02:18 ET | 600 | 12.71 |
02:20 ET | 779 | 12.72 |
02:22 ET | 509 | 12.74 |
02:24 ET | 100 | 12.745 |
02:26 ET | 203 | 12.745 |
02:27 ET | 3654 | 12.76 |
02:29 ET | 6286 | 12.75 |
02:31 ET | 2803 | 12.8 |
02:33 ET | 600 | 12.8 |
02:36 ET | 600 | 12.8 |
02:38 ET | 3871 | 12.83 |
02:40 ET | 571 | 12.8 |
02:42 ET | 400 | 12.805 |
02:44 ET | 1010 | 12.8 |
02:45 ET | 100 | 12.78 |
02:47 ET | 400 | 12.78 |
02:49 ET | 200 | 12.77 |
02:51 ET | 9915 | 12.78 |
02:54 ET | 100 | 12.7401 |
02:56 ET | 2700 | 12.805 |
02:58 ET | 879 | 12.79 |
03:00 ET | 2000 | 12.79 |
03:02 ET | 2743 | 12.81 |
03:03 ET | 211 | 12.8084 |
03:05 ET | 232 | 12.81 |
03:07 ET | 299 | 12.8 |
03:09 ET | 1109 | 12.81 |
03:12 ET | 1300 | 12.8 |
03:14 ET | 4627 | 12.835 |
03:16 ET | 1400 | 12.82 |
03:18 ET | 1400 | 12.825 |
03:20 ET | 1515 | 12.775 |
03:21 ET | 3069 | 12.825 |
03:23 ET | 2062 | 12.813 |
03:25 ET | 4128 | 12.9 |
03:27 ET | 2411 | 12.885 |
03:30 ET | 2417 | 12.88 |
03:32 ET | 4176 | 12.88 |
03:34 ET | 9662 | 13.05 |
03:36 ET | 2458 | 13.125 |
03:38 ET | 4595 | 13.11 |
03:39 ET | 2211 | 13.119 |
03:41 ET | 4658 | 13.12 |
03:43 ET | 2705 | 13.145 |
03:45 ET | 3857 | 13.14 |
03:48 ET | 2313 | 13.13 |
03:50 ET | 2172 | 13.1 |
03:52 ET | 8365 | 13.14 |
03:54 ET | 5812 | 13.14 |
03:56 ET | 12547 | 13.11 |
03:57 ET | 6907 | 13.115 |
03:59 ET | 18272 | 13.08 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Regenxbio Inc | 647.7M | -2.2x | --- |
SAGE Therapeutics Inc | 653.0M | -1.4x | --- |
Zymeworks Inc | 661.8M | -5.1x | --- |
Y-mAbs Therapeutics Inc | 527.5M | -24.3x | --- |
Editas Medicine Inc | 496.7M | -2.6x | --- |
Urogen Pharma Ltd | 459.6M | -5.2x | --- |
REGENXBIO Inc. is a clinical-stage biotechnology company seeking to improve lives through the curative potential of gene therapy. The Company has developed a pipeline of gene therapy programs using its proprietary adeno-associated virus (AAV) gene therapy delivery platform (NAV Technology Platform) to address genetic diseases. The Company is focused on its internal development pipeline in three areas: retinal, neuromuscular and neurodegenerative diseases. Its investigational AAV therapeutics include ABBV-RGX-314, RGX-202 and RGX-121. It is developing ABBV-RGX-314 in collaboration with AbbVie to treat large patient populations impacted by wet age-related macular degeneration, diabetic retinopathy (DR) and other chronic retinal diseases characterized by loss of vision. It is developing RGX-202 to treat Duchenne muscular dystrophy (Duchenne). The Company is developing RGX-121 to treat Mucopolysaccharidosis type II (MPS II), a progressive, neurodegenerative lysosomal storage disorder.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $647.7M |
---|---|
Revenue (TTM) | $86.7M |
Shares Outstanding | 49.3M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.28 |
EPS | $-5.88 |
Book Value | $7.08 |
P/E Ratio | -2.2x |
Price/Sales (TTM) | 7.5 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -306.52% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.